JANIK, Adrianna, Maria TORRENTE, Luca COSTABELLO, Virginia CALVO, Brian WALSH, Carlos CAMPS, Sameh K MOHAMED, Ana L ORTEGA, Vít NOVÁČEK, Bartomeu MASSUTÍ, Pasquale MINERVINI, M Rosario GARCIA CAMPELO, Edel del BARCO, Joaquim BOSCH-BARRERA, Ernestina MENASALVAS, Mohan TIMILSINA a Mariano PROVENCIO. Machine Learning–Assisted Recurrence Prediction for Patients With Early-Stage Non–Small-Cell Lung Cancer. JCO CLINICAL CANCER INFORMATICS. UNITED STATES: LIPPINCOTT WILLIAMS & WILKINS, 2023, roč. 7, e2200062, s. 1-11. ISSN 2473-4276. Dostupné z: https://dx.doi.org/10.1200/CCI.22.00062.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Machine Learning–Assisted Recurrence Prediction for Patients With Early-Stage Non–Small-Cell Lung Cancer
Autoři JANIK, Adrianna (garant), Maria TORRENTE, Luca COSTABELLO, Virginia CALVO, Brian WALSH, Carlos CAMPS, Sameh K MOHAMED, Ana L ORTEGA, Vít NOVÁČEK (203 Česká republika, domácí), Bartomeu MASSUTÍ, Pasquale MINERVINI, M Rosario GARCIA CAMPELO, Edel del BARCO, Joaquim BOSCH-BARRERA, Ernestina MENASALVAS, Mohan TIMILSINA a Mariano PROVENCIO.
Vydání JCO CLINICAL CANCER INFORMATICS, UNITED STATES, LIPPINCOTT WILLIAMS & WILKINS, 2023, 2473-4276.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 10201 Computer sciences, information science, bioinformatics
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 4.200 v roce 2022
Kód RIV RIV/00216224:14330/23:00131337
Organizační jednotka Fakulta informatiky
Doi http://dx.doi.org/10.1200/CCI.22.00062
UT WoS 001133302300003
Klíčová slova česky relapse prediction, machine learning, explainability, health informatics, lung cancer
Klíčová slova anglicky relapse prediction; machine learning; explainability; health informatics; lung cancer
Štítky Artificial Intelligence, machine learning, medical informatics
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnil: RNDr. Pavel Šmerk, Ph.D., učo 3880. Změněno: 10. 4. 2024 10:40.
Anotace
PURPOSE Stratifying patients with cancer according to risk of relapse can personalize their care. In this work, we provide an answer to the following research question: How to use machine learning to estimate probability of relapse in patients with early-stage non–small-cell lung cancer (NSCLC)? MATERIALS AND METHODS For predicting relapse in 1,387 patients with early-stage (I-II) NSCLC from the Spanish Lung Cancer Group data (average age 65.7 years, female 24.8%, male 75.2%), we train tabular and graph machine learning models. We generate automatic explanations for the predictions of such models. For models trained on tabular data, we adopt SHapley Additive exPlanations local explanations to gauge how each patient feature contributes to the predicted outcome. We explain graph machine learning predictions with an example-based method that highlights influential past patients. RESULTS Machine learning models trained on tabular data exhibit a 76% accuracy for the random forest model at predicting relapse evaluated with a 10-fold cross-validation (the model was trained 10 times with different independent sets of patients in test, train, and validation sets, and the reported metrics are averaged over these 10 test sets). Graph machine learning reaches 68% accuracy over a held-out test set of 200 patients, calibrated on a held-out set of 100 patients. CONCLUSION Our results show that machine learning models trained on tabular and graph data can enable objective, personalized, and reproducible prediction of relapse and, therefore, disease outcome in patients with early-stage NSCLC. With further prospective and multisite validation, and additional radiological and molecular data, this prognostic model could potentially serve as a predictive decision support tool for deciding the use of adjuvant treatments in early-stage lung cancer.
Návaznosti
MUNI/G/1763/2020, interní kód MUNázev: AIcope - AI support for Clinical Oncology and Patient Empowerment (Akronym: AIcope)
Investor: Masarykova univerzita, AIcope - AI support for Clinical Oncology and Patient Empowerment, INTERDISCIPLINARY - Mezioborové výzkumné projekty
VytisknoutZobrazeno: 2. 5. 2024 18:18